219 related articles for article (PubMed ID: 36162696)
1. Imaging-guided targeted radionuclide tumor therapy: From concept to clinical translation.
Sun J; Huangfu Z; Yang J; Wang G; Hu K; Gao M; Zhong Z
Adv Drug Deliv Rev; 2022 Nov; 190():114538. PubMed ID: 36162696
[TBL] [Abstract][Full Text] [Related]
2. Radionuclide Therapies in Molecular Imaging and Precision Medicine.
Kendi AT; Moncayo VM; Nye JA; Galt JR; Halkar R; Schuster DM
PET Clin; 2017 Jan; 12(1):93-103. PubMed ID: 27863570
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Molecular Image-Guided Cancer Radionuclide Therapy.
Gao D; Sun X; Gao L; Liu Z
Curr Drug Targets; 2015; 16(6):634-44. PubMed ID: 26028045
[TBL] [Abstract][Full Text] [Related]
4.
Li M; Sagastume EA; Lee D; McAlister D; DeGraffenreid AJ; Olewine KR; Graves S; Copping R; Mirzadeh S; Zimmerman BE; Larsen RH; Johnson FL; Schultz MK
Curr Med Chem; 2020; 27(41):7003-7031. PubMed ID: 32720598
[TBL] [Abstract][Full Text] [Related]
5. Radiotheranostics in Cancer Diagnosis and Management.
Jadvar H; Chen X; Cai W; Mahmood U
Radiology; 2018 Feb; 286(2):388-400. PubMed ID: 29356634
[TBL] [Abstract][Full Text] [Related]
6. Radiotheranostics - Precision Medicine in Nuclear Medicine and Molecular Imaging.
Duan H; Iagaru A; Aparici CM
Nanotheranostics; 2022; 6(1):103-117. PubMed ID: 34976584
[TBL] [Abstract][Full Text] [Related]
7. Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Burggasser G; Andreae F; Kurtaran A; Dudczak R
Curr Pharm Des; 2002; 8(20):1781-807. PubMed ID: 12171531
[TBL] [Abstract][Full Text] [Related]
8. A Review of Theranostics: Perspectives on Emerging Approaches and Clinical Advancements.
Burkett BJ; Bartlett DJ; McGarrah PW; Lewis AR; Johnson DR; Berberoğlu K; Pandey MK; Packard AT; Halfdanarson TR; Hruska CB; Johnson GB; Kendi AT
Radiol Imaging Cancer; 2023 Jul; 5(4):e220157. PubMed ID: 37477566
[TBL] [Abstract][Full Text] [Related]
9. Biological carrier molecules of radiopharmaceuticals for molecular cancer imaging and targeted cancer therapy.
Aerts A; Impens NR; Gijs M; D'Huyvetter M; Vanmarcke H; Ponsard B; Lahoutte T; Luxen A; Baatout S
Curr Pharm Des; 2014; 20(32):5218-44. PubMed ID: 24606796
[TBL] [Abstract][Full Text] [Related]
10. Theranostic approaches in nuclear medicine: current status and future prospects.
Filippi L; Chiaravalloti A; Schillaci O; Cianni R; Bagni O
Expert Rev Med Devices; 2020 Apr; 17(4):331-343. PubMed ID: 32157920
[No Abstract] [Full Text] [Related]
11. Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in
Plyku D; Hobbs RF; Huang K; Atkins F; Garcia C; Sgouros G; Van Nostrand D
J Nucl Med; 2017 Jul; 58(7):1146-1154. PubMed ID: 28104741
[TBL] [Abstract][Full Text] [Related]
12. Targeted alpha therapy: part I.
Elgqvist J
Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
[TBL] [Abstract][Full Text] [Related]
13. Development of Diagnostic and Therapeutic Probes with Controlled Pharmacokinetics for Use in Radiotheranostics.
Ogawa K
Chem Pharm Bull (Tokyo); 2019; 67(9):897-903. PubMed ID: 31474726
[TBL] [Abstract][Full Text] [Related]
14. Targeted radionuclide therapy--an overview.
Dash A; Knapp FF; Pillai MR
Curr Radiopharm; 2013 Sep; 6(3):152-80. PubMed ID: 24059327
[TBL] [Abstract][Full Text] [Related]
15. Radiotheranostics in oncology: current challenges and emerging opportunities.
Bodei L; Herrmann K; Schöder H; Scott AM; Lewis JS
Nat Rev Clin Oncol; 2022 Aug; 19(8):534-550. PubMed ID: 35725926
[TBL] [Abstract][Full Text] [Related]
16. Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer.
D'Huyvetter M; Xavier C; Caveliers V; Lahoutte T; Muyldermans S; Devoogdt N
Expert Opin Drug Deliv; 2014 Dec; 11(12):1939-54. PubMed ID: 25035968
[TBL] [Abstract][Full Text] [Related]
17. Targeted therapy in nuclear medicine--current status and future prospects.
Oyen WJ; Bodei L; Giammarile F; Maecke HR; Tennvall J; Luster M; Brans B
Ann Oncol; 2007 Nov; 18(11):1782-92. PubMed ID: 17434893
[TBL] [Abstract][Full Text] [Related]
18. Radionuclide cancer therapy.
Hoefnagel CA
Ann Nucl Med; 1998 Apr; 12(2):61-70. PubMed ID: 9637275
[TBL] [Abstract][Full Text] [Related]
19. Radiopharmaceuticals in the elderly cancer patient: Practical considerations, with a focus on prostate cancer therapy: A position paper from the International Society of Geriatric Oncology Task Force.
Prior JO; Gillessen S; Wirth M; Dale W; Aapro M; Oyen WJG
Eur J Cancer; 2017 May; 77():127-139. PubMed ID: 28391026
[TBL] [Abstract][Full Text] [Related]
20. [Radiotheranostics in endocrinology and oncoendocrinology].
Rumyanstsev RO
Probl Endokrinol (Mosk); 2021 Feb; 67(1):8-12. PubMed ID: 33586387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]